Related Experiment Video
Updated: Dec 23, 2025

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Melatonin Use in Hospitalized Children for Non-Anesthetic Indications: A Systematic Review
David E Procaccini1, Katie Lobner2, Blair Anton2
1Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
Insights
Melatonin supplementation appears safe for hospitalized neonates, potentially reducing inflammation. However, more research is needed in diverse pediatric populations for non-sedative uses.
Area of Science:
- Biomedical Sciences
- Pediatric Medicine
- Pharmacology
Background:
- Melatonin is a free radical scavenger crucial for physiological homeostasis.
- Increased melatonin synthesis during oxidative stress suggests therapeutic potential during acute illness.
- Limited pediatric studies hinder safe melatonin use for non-anesthetic indications.
Purpose of the Study:
- To systematically review studies on melatonin use in hospitalized pediatric patients for non-sedative and non-analgesic indications.
- To assess the safety and potential benefits of melatonin in this population.
Main Methods:
- Searched major biomedical databases (PubMed, EMBASE, CINAHL, Web of Science, Scopus).
- Included 13 eligible studies, all focusing on neonates.
- Extracted data on study design, patient numbers, indications, and melatonin regimens.
- Categorized studies by indication: antioxidant/anti-inflammatory therapy in infections, respiratory distress syndrome, neurologic injury, and jaundice.
Main Results:
- All identified studies involved neonates.
- Melatonin demonstrated safety in hospitalized neonates.
- Evidence suggests potential benefits in reducing inflammatory markers for conditions linked to oxidative stress.
- Melatonin with phototherapy was not superior to vitamin D with phototherapy for neonatal jaundice.
Conclusions:
- Current data indicate melatonin is safe for hospitalized neonates.
- Melatonin may offer anti-inflammatory benefits in neonatal conditions involving oxidative stress.
- Further research in broader pediatric populations is essential due to widespread clinical use.
Abstract:
Melatonin, a potent free radical scavenger, plays an important role in homeostasis of cell and organ physiology. The increased demand and synthesis from the pineal gland during times of oxidative stress suggests a potential benefit of melatonin supplementation during hospitalization for acute illness. Yet, the paucity of clinical studies for non-anesthetic-associated indications in pediatric populations hampers the safe, effective, and consistent use of melatonin. The objective of this study was to systematically review published studies of melatonin use for non-sedative and non-analgesic indications in hospitalized pediatric patients. We conducted a search of PubMed, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, and Scopus databases for articles on the use of melatonin for pediatric patients in a hospital setting. Thirteen eligible studies, all in neonates, were identified. Data elements extracted included study design, number of study subjects, indication for melatonin therapy, and melatonin regimen (formulation, dosage, and duration). Because study methodologies were very heterogeneous, a quantitative synthesis of the published findings was not possible. The identified studies were therefore categorized by the indication of melatonin (adjuvant-antioxidant or anti-inflammatory therapy) in the following specific disease states: (i) acute infections, (ii) respiratory distress syndrome, (iii) neurologic injury, and (iv) jaundice. The current data suggest that melatonin is safe for use in hospitalized neonates. Melatonin may be beneficial for reducing inflammatory markers in neonatal patients with disease states and clinical sequelae that are associated with increased inflammation and oxidative stress. Melatonin, in conjunction with phototherapy, is not superior to use of vitamin D with phototherapy for treatment of neonatal jaundice. However, studies in other pediatric populations are needed given widespread use across clinical inpatient settings.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Nightmares and Night Terrors
Nightmares...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Narcolepsy

